A recent study investigating multiple sclerosis (MS) showed that APRIL mediated an anti-inflammatory response in astrocytes by producing IL-10 to suppress antigen-specific T-cell proliferation and pathogenic cytokine secretion. This evidence concerns the gene TNFSF13 and myeloid sarcoma.